Trials / Unknown
UnknownNCT00994799
Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema
Comparison of the Effect of Intravitreal Ranibizumab Injections Compared to Macular Grid-pattern Laser Therapy for the Symptomatic Treatment of Diabetic Macular Edema (a Randomized, Controlled, Phase III Trial)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Szeged University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the hypothesis that ranibizumab injection given into the eye is an efficacious and safe treatment option applied for swelling of the macula (site of sharp vision) in diabetes.
Detailed description
This is a randomized, controlled, three-center trial to assess the efficacy and safety of intravitreal ranibizumab injections in diabetic macular edema. Comparator arm consists of patients receiving macular grid-pattern laser therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ranibizumab | 10mg/ml intravitreal injection |
| RADIATION | macular grid-pattern laser | macular grid-pattern laser therapy |
Timeline
- Start date
- 2009-07-01
- Completion
- 2011-02-01
- First posted
- 2009-10-14
- Last updated
- 2009-10-16
Locations
3 sites across 1 country: Hungary
Source: ClinicalTrials.gov record NCT00994799. Inclusion in this directory is not an endorsement.